PRESS RELEASE published on 02/11/2025 at 12:30, 1 year 7 months ago NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape NanoViricides, Inc. declares readiness to combat bird flu with broad-spectrum antiviral drug NV-387. Scientific discussion on virus mutations and potential effectiveness against H5N1. Focus on Trump administration's response NV-387 NanoViricides Inc. Antiviral Drug H5N1 Bird Flu
BRIEF published on 01/29/2025 at 12:35, 1 year 7 months ago NanoViricides to Present at MicroCap Conference 2025 NanoViricides NV-387 Microcap Conference Clinical Trials Antiviral Drug
BRIEF published on 01/29/2025 at 12:35, 1 year 7 months ago NanoViricides sera présenté à la conférence MicroCap 2025 NanoViricides NV-387 Essais Cliniques Conférence MicroCap Médicament Antiviral
PRESS RELEASE published on 01/29/2025 at 12:30, 1 year 7 months ago NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025 NanoViricides, Inc. presents its groundbreaking broad-spectrum antiviral drug NV-387 at MicroCap Conference 2025, showing promising results against various viral infections NanoViricides NV-387 Microcap Conference Antiviral Drug Viral Infections
BRIEF published on 01/27/2025 at 12:35, 1 year 7 months ago NanoViricides Advances NV-387 to Phase II Clinical Trial NanoViricides NV-387 Clinical Trial Antiviral Drug MPOX Treatment
BRIEF published on 01/27/2025 at 12:35, 1 year 7 months ago NanoViricides fait passer le NV-387 à l'essai clinique de phase II NanoViricides NV-387 Essai Clinique Médicament Antiviral Traitement MPox
PRESS RELEASE published on 01/27/2025 at 12:30, 1 year 7 months ago NanoViricides Engages CRO for Phase II Clinical Trial NanoViricides, Inc. engages a Clinical Research Organization for Phase II trial of broad-spectrum antiviral drug NV-387 targeting MPox virus infection. Drug aims to combat viral diseases effectively NanoViricides NV-387 Clinical Trial Antiviral Drug Mpox Virus
BRIEF published on 01/13/2025 at 12:35, 1 year 8 months ago NanoViricides to Present Breakthrough Antiviral Developments at Biotech Showcase NanoViricides NV-387 Biotech Showcase Clinical Trials Antiviral Drugs
BRIEF published on 01/13/2025 at 12:35, 1 year 8 months ago NanoViricides présentera ses avancées antivirales révolutionnaires au Biotech Showcase NanoViricides NV-387 Essais Cliniques Médicaments Antiviraux Vitrine Biotechnologique
PRESS RELEASE published on 01/13/2025 at 12:30, 1 year 8 months ago NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025 NanoViricides, Inc. to present Phase II-ready drug NV-387 at Biotech Showcase 2025 in San Francisco, demonstrating broad-spectrum antiviral activity against various infections NV-387 NanoViricides Inc. Antiviral Drug San Francisco Biotech Showcase 2025
Published on 09/25/2026 at 07:30, 5 hours 3 minutes ago Tocvan Reports Positive Closed-Circuit Column Leach Results at Gran Pilar
Published on 09/25/2026 at 00:30, 12 hours 3 minutes ago Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Published on 09/25/2026 at 00:15, 12 hours 18 minutes ago CoTec Holdings Corp. Announces Extension of Private Placement of Unsecured Convertible Debentures
Published on 09/24/2026 at 22:01, 14 hours 32 minutes ago Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/25/2026 at 12:26, 6 minutes ago VitrA Tiles Introduces "The Code" concept and the New Codes of Design at Cersaie Fair
Published on 09/25/2026 at 10:00, 2 hours 32 minutes ago AI and supply chains open new pathways to systemic stress as risks become more interconnected, find Swiss Re Institute and LSE
Published on 09/25/2026 at 09:09, 3 hours 23 minutes ago flatexDEGIRO sets course for next phase of growth
Published on 09/25/2026 at 07:00, 5 hours 32 minutes ago ENGIE mobilise une aide exceptionnelle de 54 millions d'euros pour soutenir les ménages les plus fragiles face à la hausse des prix de l'énergie
Published on 09/24/2026 at 18:31, 18 hours 1 minute ago LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:00, 18 hours 33 minutes ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 18 hours 33 minutes ago GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
